Jingliang Zhang, PhD, is a Research Scientist at Purdue University whose work investigates how SCN2A gene mutations disrupt brain development and lead to autism and epilepsy. His research integrates advanced electrophysiology, rodent models, human brain organoids, and gene-based therapeutic strategies to define the mechanisms underlying impaired neuronal activity. Through these efforts, he aims to clarify the principles of neural circuit dysfunction and drive the development of precision treatments. His work has been published in high-impact journals and supported by the FamilieSCN2A Foundation, and he is committed to translating neuroscience discoveries into therapies for individuals and
families affected by SCN2A-related disorders.
Jingliang Zhang, PhD
